Impact of the <sup>18</sup>F-FDG-PET/MRI on Metastatic Staging in Patients with Hepatocellular Carcinoma: Initial Results from 104 Patients

Impact of the <sup>18</sup>F-FDG-PET/MRI on Metastatic Staging in Patients with Hepatocellular Carcinoma: Initial Results from 104 Patients

Optimal HCC therapeutic management relies on accurate tumor staging. Our aim was to assess the impact of <sup>18</sup>F-FDG-WB-PET/MRI on HCC metastatic staging, compared with the standard of care CT-CAP/liver MRI combination, in patients with HCC referred on a curative intent or before...

Full description

Bibliographic Details
Main Authors: Mathilde Vermersch, Sébastien Mulé, Julia Chalaye, Athena Galletto Pregliasco, Berivan Emsen, Giuliana Amaddeo, Aurélien Monnet, Alto Stemmer, Laurence Baranes, Alexis Laurent, Vincent Leroy, Emmanuel Itti, Alain Luciani
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Journal of Clinical Medicine
Subjects:
hepatocellular carcinoma
staging
metastases
PET/MRI
<sup>18</sup>F-Fluoro-Desoxy-Glucose
Online Access:https://www.mdpi.com/2077-0383/10/17/4017

Internet

https://www.mdpi.com/2077-0383/10/17/4017

Similar Items